Researchers explored brain white matter integrity in superagers, older adults with exceptional cognitive abilities, finding that while overall white matter health showed no significant differences, superagers displayed superior microstructure in frontal regions, potentially explaining their resistance to cognitive decline.
Coherus to buy Surface Oncology in stock deal valued at $65M
Coherus BioSciences is making a small stock-for-stock transaction to shore up its immuno-oncology pipeline in an acquisition of Surface Oncology that is valued at $65